Barratt Developments Plc:企業の戦略・SWOT・財務情報

◆英語タイトル:Barratt Developments Plc - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C9111
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:建設・建築
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Barratt Developments Plc – Strategy, SWOT and Corporate Finance Report
Summary

Barratt Developments Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Barratt Developments PLC (Barratt) is a commercial property developer and residential construction contractor. The company designs, builds and sells houses and commercial developments. The company develops homes under the brands of Barratt Homes, David Wilson Homes and Ward Homes; commercial and mixed-use developments under the Wilson Bowden Developments brand. The company operates through house building and commercial developments divisions. In house building division, the company develops traditional housing, apartments and urban regeneration projects. The commercial developments division develops commercial and mixed-use property portfolio that comprises leisure, retail, office and mixed use properties. It operates across Great Britain. Barratt is headquartered in Coalville, Leicestershire, the UK.

Scope

- Detailed information on Barratt Developments Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Barratt Developments Plc in the form of a SWOT analysis
- An in-depth view of the business model of Barratt Developments Plc including a breakdown and examination of key business segments
- Intelligence on Barratt Developments Plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Barratt Developments Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Barratt Developments Plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Barratt Developments Plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Barratt Developments Plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Barratt Developments Plc: Company Overview 9
Barratt Developments Plc: Overview and Key Facts 9
Barratt Developments Plc: Overview 9
Barratt Developments Plc: Key Facts 9
Barratt Developments Plc: Key Employees 11
Barratt Developments Plc: Key Employee Biographies 12
Barratt Developments Plc: Major Products and Services 14
Barratt Developments Plc: Company History 15
Barratt Developments Plc: Management Statement 18
Barratt Developments Plc: Locations and Subsidiaries 20
Barratt Developments Plc: Key Competitors 22
Barratt Developments Plc: Company Analysis 23
Barratt Developments Plc: Business Description 23
Barratt Developments Plc: SWOT Analysis 24
Barratt Developments Plc: SWOT Overview 24
Barratt Developments Plc: Strengths 24
Barratt Developments Plc: Weaknesses 25
Barratt Developments Plc: Opportunities 25
Barratt Developments Plc: Threats 25
Barratt Developments Plc: Corporate Financial Deals Activity 27
Barratt Developments Plc: Financial Deals Overview 27
Barratt Developments Plc: Top Deals 2014 – 2018YTD* 28
Barratt Developments Plc: Divestments 29
Barratt Developments Plc: Recent Developments 30
Barratt Developments Plc: News and Events Summary 30
Barratt Developments Plc: Business Expansion 33
Barratt Developments Plc: Contracts 34
Barratt Developments Plc: Corporate Governance 35
Barratt Developments Plc: Financial Performance 35
Barratt Developments Plc: Regulatory and Legal Events 35
Barratt Developments Plc: Strategy and Operations 36
Appendix 37
Contact Us 37
Methodology 37
About MarketLine 38

List of Tables
Table 1: Barratt Developments Plc: Key Facts
Table 2: Barratt Developments Plc: Key Employees
Table 3: Barratt Developments Plc: Company History
Table 4: Barratt Developments Plc: Locations and Subsidiaries
Table 5: Barratt Developments Plc: Key Competitors
Table 6: Barratt Developments Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Barratt Developments Plc: Top Deals 2014 - 2018YTD*
Table 8: Barratt Developments Plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 9: Barratt Developments Plc: News and Events Summary
Table 10: Barratt Developments Plc: Business Expansion
Table 11: Barratt Developments Plc: Contracts
Table 12: Barratt Developments Plc: Corporate Governance
Table 13: Barratt Developments Plc: Financial Performance
Table 14: Barratt Developments Plc: Regulatory and Legal Events
Table 15: Barratt Developments Plc: Strategy and Operations

List of Figures
Figure 1: Barratt Developments Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Barratt Developments Plc: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Barratt Developments Plc:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Yantai Dongcheng Pharmaceutical Group Co Ltd (002675):製薬・医療:M&Aディール及び事業提携情報
    Summary Yantai Dongcheng Pharmaceutical Group Co Ltd (Yantai Dongcheng Pharma), formerly Yantai Dongcheng Biochemicals Co Ltd, is a developer, manufacturer, and marketer of biochemical API, chemical synthetic drugs, and Chinese medicines. The company offers its products under categories including he …
  • Santos Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Santos Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Santos Ltd (Santos) is an independent oil and natural gas company. Its activities include onshore, offshore and liquefied natural gas (LNG) projects. The company has exploration and production acreage in …
  • Valeant Pharmaceuticals International, Inc.:企業のM&A・事業提携・投資動向
    Valeant Pharmaceuticals International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Valeant Pharmaceuticals International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • The Royal Bank of Scotland Group Plc:企業のM&A・事業提携・投資動向
    The Royal Bank of Scotland Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Royal Bank of Scotland Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Consumers Energy Company:発電所・企業SWOT分析
    Consumers Energy Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Inoviem Scientific SAS-製薬・医療分野:企業M&A・提携分析
    Summary Inoviem Scientific SAS (Inoviem) is a contract research biotechnology company that offers preclinical and clinical services. The company develops solutions in the field of drug target interaction analysis and drug development. Its technologies include physiological intermolecular modulation …
  • ABM Industries Incorporated (ABM):企業の財務・戦略的SWOT分析
    ABM Industries Incorporated (ABM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • China Power Clean Energy Development Co Ltd (735):企業の財務・戦略的SWOT分析
    China Power Clean Energy Development Co Ltd (735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Disco Corp (6146):企業の財務・戦略的SWOT分析
    Disco Corp (6146) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Rizal Commercial Banking Corp (RCB):企業の財務・戦略的SWOT分析
    Summary Rizal Commercial Banking Corp (RCBC) is a commercial and financial banking service provider that offers corporate, commercial, and consumer banking, cash management, treasury, and remittance products and services. The company’s electronic banking services include mobile banking, internet ban …
  • Lab21 Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Lab21 Ltd (Lab21), a subsidiary of Novacyt SA, is a clinical laboratory that offers clinical diagnostic testing services. The company develops molecular diagnostics for oncology and virology. Its oncology includes KRAS, EGFR, BRAF, ALK, RAS-RAF, BRCA, prostate cancer, among others. Lab21’s v …
  • Ryerson Holding Corp:企業の戦略・SWOT・財務情報
    Ryerson Holding Corp - Strategy, SWOT and Corporate Finance Report Summary Ryerson Holding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Grupo Herdez SA de CV:企業の戦略・SWOT・財務情報
    Grupo Herdez SA de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Herdez SA de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • iBio Inc (IBIO):医療機器:M&Aディール及び事業提携情報
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • University Health Network-製薬・医療分野:企業M&A・提携分析
    Summary University Health Network (UHN) is a health care institution that provides patient care, research and educational services, and patient support services. It offers health care services such as palliative care, pharmacy and telehealth. UHN also provides specialized program services, accessibi …
  • BP Plc (BP.)-石油・ガス分野:企業M&A・提携分析
    Summary BP p.l.c. (BP) is an integrated oil and gas company. It provides fuel, energy, lubricants and petrochemicals to its customers. Its upstream activities include oil and natural gas exploration, field development and production; and midstream operations include transportation, and marketing and …
  • Hermes International SA:企業の戦略・SWOT・財務情報
    Hermes International SA - Strategy, SWOT and Corporate Finance Report Summary Hermes International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • CIC Insurance Group Limited (CIC):企業の財務・戦略的SWOT分析
    CIC Insurance Group Limited (CIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Nippon Shokubai Co Ltd (4114):企業の財務・戦略的SWOT分析
    Nippon Shokubai Co Ltd (4114) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Biomay AG-製薬・医療分野:企業M&A・提携分析
    Summary Biomay AG (Biomay) discovers and develops disease modifying allergy therapeutics. The company develops peptide carrier fusion vaccines for allergy immunotherapy. Its pipeline product portfolio comprises investigation candidates targeted against IgE mediated diseases, grass pollen allergy, ho …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆